Management ChangeMay 4, 2026, 04:13 PM
Valion Bio Appoints Melinda Lackey as General Counsel
AI Summary
Valion Bio, Inc. (formerly Tivic Health Systems, Inc.) announced the appointment of Melinda Lackey as General Counsel and Senior Vice President of Legal Affairs, effective May 4, 2026. Ms. Lackey brings over 18 years of legal and corporate experience, including executive and legal leadership roles at biotechnology companies like Alaunos Therapeutics and Kuur Therapeutics. Her compensation package includes an annual base salary of $321,000, eligibility for an annual incentive bonus up to 35% of her base salary, and an option to purchase 45,000 shares of common stock. This appointment is strategic as Valion Bio advances Entolimod™ and scales its CDMO subsidiary, Velocity Bioworks.
Key Highlights
- Melinda Lackey appointed General Counsel and Senior Vice President of Legal Affairs of Valion Bio, Inc. on May 4, 2026.
- Ms. Lackey will receive an annual base salary of $321,000.
- She is eligible for an annual incentive bonus up to 35% of her base salary.
- Ms. Lackey was granted an option to purchase 45,000 shares of common stock.
- She previously served as SVP, Legal & Administration at Alaunos Therapeutics from Nov 2021 to Aug 2025.
- Her experience includes legal leadership roles at clinical-stage biotechnology companies and international law firms.
- Her employment is at-will, with specific severance terms for termination without cause or for good reason.
Price Impact
More from TIVC